These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

227 related items for PubMed ID: 1963696

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Multimodality treatment for patients with hepatocellular carcinoma: a single institution retrospective series.
    Takano S, Watanabe Y, Ohishi H, Kono S, Nakamura M, Kubota N, Iwai S.
    Eur J Surg Oncol; 2000 Feb; 26(1):67-72. PubMed ID: 10718183
    [Abstract] [Full Text] [Related]

  • 3. [Non-surgical (medical) treatment of hepatocellular carcinoma (HCC)].
    Tanikawa K.
    Gan To Kagaku Ryoho; 1989 Jan; 16(1):34-9. PubMed ID: 2536269
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of transcatheter arterial embolization prior to percutaneous tumor ablation in patients with hepatocellular carcinoma: a randomized controlled trial.
    Akamatsu M, Yoshida H, Obi S, Sato S, Koike Y, Fujishima T, Tateishi R, Imamura M, Hamamura K, Teratani T, Shiina S, Ishikawa T, Omata M.
    Liver Int; 2004 Dec; 24(6):625-9. PubMed ID: 15566514
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Combination therapy with transcatheter arterial embolization and percutaneous ethanol injection for advanced hepatocellular carcinoma.
    Koda M, Okamoto K, Miyoshi Y, Kato S, Murawaki Y, Horie Y, Suou T, Kawasaki H.
    Hepatogastroenterology; 1994 Feb; 41(1):25-9. PubMed ID: 8175109
    [Abstract] [Full Text] [Related]

  • 7. Long-term follow-up of hepatic arterial chemoembolization with cisplatin suspended in iodized oil for hepatocellular carcinoma.
    Maeda S, Shibata J, Fujiyama S, Tanaka M, Noumaru S, Sato K, Tomita K.
    Hepatogastroenterology; 2003 Feb; 50(51):809-13. PubMed ID: 12828090
    [Abstract] [Full Text] [Related]

  • 8. Combination of transcatheter arterial embolization and percutaneous ethanol injection for hepatocellular carcinoma: comparison of efficacies of doxorubicin and epirubicin in transcatheter arterial embolization.
    Nakamura S, Tanaka K.
    Semin Oncol; 1997 Apr; 24(2 Suppl 6):S6-46-S6-49. PubMed ID: 9151916
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Transcatheter arterial embolization in hepatocellular carcinoma: a long-term follow-up.
    Nakao N, Kamino K, Miura K, Takayasu Y, Ohnishi M, Miura T.
    Radiat Med; 1992 Apr; 10(1):13-8. PubMed ID: 1316626
    [Abstract] [Full Text] [Related]

  • 11. Factors associated with survival exceeding 5 years after transcatheter arterial embolization for hepatocellular carcinoma.
    Yoshioka H, Sato M, Sonomura T, Terada M, Kishi K, Yoshikawa A.
    Semin Oncol; 1997 Apr; 24(2 Suppl 6):S6-29-S6-37. PubMed ID: 9151914
    [Abstract] [Full Text] [Related]

  • 12. Transcatheter arterial chemoembolization therapy combined with percutaneous ethanol injection for unresectable large hepatocellular carcinoma: an evaluation of the local therapeutic effect and survival rate.
    Dohmen K, Shirahama M, Shigematsu H, Miyamoto Y, Torii Y, Irie K, Ishibashi H.
    Hepatogastroenterology; 2001 Apr; 48(41):1409-15. PubMed ID: 11677976
    [Abstract] [Full Text] [Related]

  • 13. [Intra-arterial chemotherapy for the treatment of advanced hepatocellular carcinoma through implantable port (reservoir)].
    Motohara T, Ozawa Z, Morita S.
    Gan To Kagaku Ryoho; 1994 Nov; 21(15):2645-8. PubMed ID: 7979426
    [Abstract] [Full Text] [Related]

  • 14. Effect of percutaneous ethanol injection for postoperative recurrence of hepatocellular carcinoma in combination with transcatheter arterial embolization.
    Ishii H, Okada S, Sato T, Nose H, Okusaka T, Yoshimori M, Takayasu K, Takayama T, Kosuge T, Yamasaki S.
    Hepatogastroenterology; 1996 Nov; 43(9):644-50. PubMed ID: 8799409
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Significance of arterial infusion of SMANCS-dissolved Lipiodol in therapeutic strategies for hepatocellular carcinoma].
    Jin-no K.
    Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():90-8. PubMed ID: 9512695
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Combination of transcatheter arterial infusion of SMANCS and embolization (SMANCS-TAE) for hepatocellular carcinoma].
    Hirashima N.
    Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():125-32. PubMed ID: 9512700
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.